Dapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries

European Urology

Volumn 55, Issue 4, 2009, Pages 957-968

  Buvat, Jacques ^a   Tesfaye, Fisseha ^b   Rothman, Margaret ^b   Rivas, David A ^b   Giuliano, François ^c  

^a CETPARP/Le grand Hunier   (France)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Dapoxetine; Distress; Intravaginal ejaculatory latency time; Perceived control over ejaculation; Premature ejaculation; Selective serotonin reuptake inhibitor

Indexed keywords

DAPOXETINE; PLACEBO;

ABDOMINAL PAIN; ADULT; ANXIETY; ARTICLE; ASTHENIA; BACKACHE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; ERECTILE DYSFUNCTION; FATIGUE; HEADACHE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERHIDROSIS; INFLUENZA; INSOMNIA; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PARALLEL DESIGN; PHASE 3 CLINICAL TRIAL; PREMATURE EJACULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SEXUAL INTERCOURSE; SIDE EFFECT; SINUS ARREST; SINUS BRADYCARDIA; SOMNOLENCE; SYNCOPE; TRANSIENT ISCHEMIC ATTACK; UNCONSCIOUSNESS; VOMITING; XEROSTOMIA;

ADULT; BENZYLAMINES; DOUBLE-BLIND METHOD; EJACULATION; HUMANS; MALE; NAPHTHALENES; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 60249103913     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.01.025     Document Type: Article

References (14)

1. Modi N.B., Dresser M.J., Simon M., Lin D., Desai D., and Gupta S. Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. J Clin Pharmacol 46 (2006) 301-309
2. Pryor J.L., Althof S.E., Steidle C., et al. Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation: integrated analysis of two randomized, double-blind, placebo-controlled trials. Lancet 368 (2006) 929-937
3. Kaufman JM, Rosen RC, Mudumbi RV, Tesfaye F, Hashmonay R, Rivas D. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial. BJU Int. In press. doi:10.1111/j.1464-410X.2008.08165.x.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text revision. Washington, DC: American Psychiatric Association;2000.
5. Giuliano F., Levine S.B., Buvat J., et al. Lack of withdrawal syndrome or effects on anxiety with dapoxetine (DPX) for the treatment of premature ejaculation (PE): results from 2 phase III trials [abstract]. Eur Urol Suppl 7 (2008) 187
6. Patrick D.L., Althof S.E., Pryor J.L., et al. Premature ejaculation: an observational study of men and their partners. J Sex Med 2 (2005) 358-367
7. Giuliano F., Patrick D.L., Porst H., et al. Premature ejaculation: results from a five-country European observational study. Eur Urol 53 (2008) 1048-1057
8. Brock G., Buvat J., Giuliano F., et al. Improvement in sexual satisfaction of female partners of men with premature ejaculation (PE) treated with dapoxetine (DPX) [abstract]. J Urol 179 (2008) 431-432
9. McMahon C.G., Althof S., Waldinger M.D., et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. BJU Int 102 (2008) 338-350
10. McMahon C.G. Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies-part II-study design, outcome measures, data analysis, and reporting. J Sex Med 5 (2008) 1817-1833
11. Waldinger M.D., Zwinderman A.H., Olivier B., and Schweitzer D.H. Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy. J Sex Med 5 (2008) 492-499
12. Shabsigh R., Patrick D.L., Rowland D.L., Bull S.A., Tesfaye F., and Rothman M. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine. BJU Int 102 (2008) 824-828
13. McKillop C. Interview with Dr Francois Giuliano. New avenues in the pharmacological treatment of premature ejaculation. Eur Urol 52 (2007) 1254-1257
14. Modi N.B., Nath R., Wang B., Rivas D., and Gupta S. Dapoxetine has no effects on hemodynamics or electrocardiographic assessments [abstract]. J Sex Med 5 (2008) 90-91